“In-silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues as Dual Inhibitors Targeting Breast Cancer” (2021) Asian Journal of Pharmaceutical and Health Sciences, 11(2), pp. 2468–2474. doi:10.5530/qsrddd17.